Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds

Traumatic brain injury is common, and often results in debilitating consequences. Even mild traumatic brain injury leaves approximately 20% of patients with symptoms that persist for months. Despite great clinical need there are currently no approved pharmaceutical interventions that improve outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Lins, Brittney R., Anyaegbu, Chidozie C., Hellewell, Sarah C., Papini, Melissa, McGonigle, Terence, De Prato, Luca, Shales, Matthew, Fitzgerald, Melinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026409/
https://www.ncbi.nlm.nih.gov/pubmed/36935484
http://dx.doi.org/10.1186/s12974-023-02734-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026409/
https://www.ncbi.nlm.nih.gov/pubmed/36935484
http://dx.doi.org/10.1186/s12974-023-02734-9

Ejemplares similares